Hanyu Pharmaceutical Co., Ltd.: Simigrup API is accepted by FDA in the United States

[Hanyu Pharmaceutical Co., Ltd.: Simiguelu Peptide API accepted by FDA] Financial Associated Press, June 14 / PRNewswire-FirstCall-Asianet /-- Hanyu Pharmaceutical announced that its product Simigrup API has been accepted by the FDA of the United States. The drug is used to lose weight in specific patients, reduce blood sugar levels in patients with type 2 diabetes and reduce the risk of major cardiovascular events, such as heart attacks or strokes.